Rocha Rodolfo V, Lindsay Thomas F, Nasir Daniyal, Lee Douglas S, Austin Peter C, Chan Justin, Chung Jennifer C Y, Forbes Thomas L, Ouzounian Maral
Division of Cardiovascular Surgery, Peter Munk Cardiac Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Division of Vascular Surgery, Peter Munk Cardiac Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
J Vasc Surg. 2022 Apr;75(4):1135-1141.e3. doi: 10.1016/j.jvs.2021.09.021. Epub 2021 Oct 2.
We sought to determine the risk factors associated with late mortality or complications (thoracoabdominal aortic aneurysm [TAAA] life-altering events [TALE]: a composite of mortality, permanent paraplegia, permanent dialysis, and stroke) for patients who had undergone endovascular or open TAAA repair.
We performed a population-based study of patients who had undergone TAAA repair in Ontario, Canada, from 2006 to 2017. The association of baseline risk factors with mortality and complications after repair was examined using Cox hazards models with hospital-specific random effects. The survival of patients who had undergone TAAA repair was compared with that of controls without TAAAs. The two groups were matched by age, sex, area of residence, and average annual household income. The type of repair (endovascular vs open) was included in all models.
We identified 664 adults (mean age, 69.3 ± 10.6 years; 71% men) who had undergone TAAA repair. At 5 and 8 years, survival was 55.0% (95% confidence interval [CI], 49.8%-60.1%) and 44.6% (95% CI, 40.4%-49.6%) for patients who had undergone TAAA repair vs 85.6% (95% CI, 83.9%-87.1%) and 76.3% (95% CI, 73.8%-78.8%) for the control population, respectively (hazard ratio [HR], 1.97; 95% CI, 1.67-2.32; P < .01). For the TAAA group, freedom from TALE was 49.2% (95% CI, 44.7%-53.7%) and 37.3% (95% CI, 33.1%-42.4%) at 5 and 8 years of follow-up, respectively. On multivariable analysis, the risk factors associated with mortality during follow-up included older age (HR, 1.21 per 5-year increase; 95% CI, 1.13-1.28), peripheral artery disease (HR, 1.46; 95% CI, 1.03-2.09), hypertension (HR, 1.58; 95% CI, 1.03-2.43), congestive heart failure (HR, 1.78; 95% CI, 1.34-2.36), and urgent procedures (HR, 2.27; 95% CI, 1.74-3.00). A lower rate of death was observed for those with previous coronary revascularization (HR, 0.63; 95% CI, 0.41-0.96) and those who had undergone repair at high-volume institutions (>60 TAAA repairs during the study period; HR, 0.71; 95% CI, 0.55-0.91). Older age, chronic kidney disease, congestive heart failure, and urgent procedures were associated with a higher rate of TALE. The type of repair (endovascular vs open) was not associated with mortality or TALE.
TAAA repair was associated with reduced long-term survival compared with the general population, regardless of the mode of treatment. Urgent or emergent repair was the most profound risk factor for late adverse events. The type of repair (endovascular vs open) was not a predictor of long-term death or complications. Previous coronary revascularization and treatment performed at a high-volume institution were associated with improved late outcomes for patients undergoing TAAA repair.
我们试图确定接受血管腔内或开放性胸腹主动脉瘤(TAAA)修复术的患者发生晚期死亡或并发症(TAAA改变生活事件[TALE]:死亡、永久性截瘫、永久性透析和中风的综合)的相关危险因素。
我们对2006年至2017年在加拿大安大略省接受TAAA修复术的患者进行了一项基于人群的研究。使用具有医院特定随机效应的Cox风险模型检查基线危险因素与修复后死亡率和并发症之间的关联。将接受TAAA修复术的患者的生存率与无TAAA的对照组的生存率进行比较。两组按年龄、性别、居住地区和家庭平均年收入进行匹配。所有模型均纳入修复类型(血管腔内修复与开放性修复)。
我们确定了664例接受TAAA修复术的成年人(平均年龄69.3±10.6岁;71%为男性)。在5年和8年时,接受TAAA修复术的患者的生存率分别为55.0%(95%置信区间[CI],49.8%-60.1%)和44.6%(95%CI,40.4%-49.6%),而对照组人群的生存率分别为85.6%(95%CI,83.9%-87.1%)和76.3%(95%CI,73.8%-78.8%)(风险比[HR],1.97;95%CI,1.67-2.32;P<.01)。对于TAAA组,在随访5年和8年时,无TALE的比例分别为49.2%(95%CI,44.7%-53.7%)和37.3%(95%CI,33.1%-42.4%)。多变量分析显示,随访期间与死亡相关的危险因素包括年龄较大(每增加5岁HR为1.21;95%CI,1.13-1.28)、外周动脉疾病(HR,1.46;95%CI,1.03-2.09)、高血压(HR,1.58;95%CI,1.03-2.43)、充血性心力衰竭(HR,1.78;95%CI,1.34-2.36)和急诊手术(HR,2.27;95%CI,1.74-3.00)。既往有冠状动脉血运重建的患者(HR,0.63;95%CI,0.41-0.96)和在高容量机构接受修复的患者(研究期间>60例TAAA修复术;HR,0.71;95%CI,0.55-0.91)的死亡率较低。年龄较大、慢性肾病、充血性心力衰竭和急诊手术与较高的TALE发生率相关。修复类型(血管腔内修复与开放性修复)与死亡率或TALE无关。
与普通人群相比,无论治疗方式如何,TAAA修复术均与长期生存率降低相关。急诊或紧急修复是晚期不良事件最主要的危险因素。修复类型(血管腔内修复与开放性修复)不是长期死亡或并发症的预测因素。既往冠状动脉血运重建和在高容量机构进行的治疗与接受TAAA修复术的患者晚期预后改善相关。